Valuation: Prenetics Global Limited

Market Cap 28Cr 25Cr 23Cr 21Cr 40Cr 2.71TCr 41Cr 274.79Cr 106.82Cr 1.33TCr 106.94Cr 104.65Cr 4.59TCr P/E 2026 *
-6.45x
P/E 2027 * -28.2x
Enterprise Value 28Cr 25Cr 23Cr 21Cr 40Cr 2.71TCr 41Cr 274.79Cr 106.82Cr 1.33TCr 106.94Cr 104.65Cr 4.59TCr EV / Sales 2026 *
1.4x
EV / Sales 2027 * 0.89x
Free-Float
85.39%
Yield 2026 *
-
Yield 2027 * -
1 day-5.37%
1 week-10.09%
Current month-11.45%
1 month-18.57%
3 months-13.97%
6 months+7.29%
Current year+7.49%
1 week 16.59
Extreme 16.59
19.46
1 month 16.59
Extreme 16.59
22.22
Current year 14
Extreme 14
23.63
1 year 7.18
Extreme 7.175
23.63
3 years 2.85
Extreme 2.85
23.63
5 years 2.85
Extreme 2.85
131.25
10 years 2.85
Extreme 2.85
131.25
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 52 01/01/2014
Chief Executive Officer 47 01/01/2014
Director of Finance/CFO 41 01/01/2018
Director TitleAgeSince
Chairman 47 01/01/2014
Director/Board Member 38 -
Director/Board Member 60 13/06/2024
Date Insider Type Main position Quantity % Market Cap.
15/06Fiscal year

Director

31,746 0.2082%
15/06Fiscal year

Director

15,625 0.1025%
04/06Other

Director

24,004 0.1574%
Change 5-day change 1-year change 3-year change Capi.($)
-5.37%-10.09%+111.62%+25.13% 28Cr
+3.49%+1.36%-29.04%-11.02% 17TCr
+5.04%+2.73%-5.88%-4.53% 11TCr
+2.80%+3.63%+0.09%+55.31% 5.77TCr
+1.33%+1.39%+55.88%+50.01% 5.38TCr
+3.39%+1.39%-10.26%-39.65% 4.36TCr
+3.50%+11.11% - - 3.65TCr
+3.47%+1.58%-14.08%-43.91% 2.75TCr
+0.20%+4.24%+64.56%-3.33% 2.58TCr
+2.78%+1.17%-8.15%-0.43% 2.13TCr
Average +2.06%+2.78%+18.30%+3.06% 5.39TCr
Weighted average by Cap. +3.31%+3.79%-3.48%+1.08%

Financials

2026 *2027 *
Net sales 20Cr 18Cr 16Cr 15Cr 29Cr 1.93TCr 29Cr 195.72Cr 76Cr 949.75Cr 76Cr 75Cr 3.27TCr 32Cr 28Cr 26Cr 24Cr 45Cr 3.04TCr 46Cr 307.94Cr 119.71Cr 1.49TCr 119.84Cr 117.27Cr 5.15TCr
Net income -4.87Cr -4.26Cr -3.91Cr -3.65Cr -6.92Cr -463.81Cr -7.02Cr -47Cr -18Cr -227.99Cr -18Cr -18Cr -785.63Cr -96.21L -84.11L -77.3L -72.05L -1.37Cr -92Cr -1.39Cr -9.28Cr -3.61Cr -45Cr -3.61Cr -3.53Cr -155.17Cr
Net Debt - -
Logo Prenetics Global Limited
Prenetics Global Ltd is a company principally engaged in the provision of diagnostic and preventive products and services. The Company operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The Company's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients. The Company is also engaged in consumer health products by a new health and wellness brand IM8.
Employees
98
Date Price Change Volume
02/26/02 $16.93 -5.37% 1,22,280
01/26/01 $17.89 -6.43% 65,868
30/26/30 $19.12 +2.91% 61,082
29/26/29 $18.58 -1.33% 86,049
26/26/26 $18.83 -4.66% 1,76,066
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
16.93USD
Average target price
31.00USD
Spread / Average Target
+83.11%

Quarterly revenue - Rate of surprise